Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Per H. Svensson is active.

Publication


Featured researches published by Per H. Svensson.


Journal of the American Chemical Society | 2013

De novo determination of the crystal structure of a large drug molecule by crystal structure prediction based powder NMR crystallography

Maria Baias; Jean-Nicolas Dumez; Per H. Svensson; Staffan Schantz; Graeme M. Day; Lyndon Emsley

The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state (1)H NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.


Journal of Medicinal Chemistry | 2012

Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.

James S. Scott; Alan Martin Birch; Katy J. Brocklehurst; Anders Broo; Hayley S. Brown; Roger John Butlin; David S. Clarke; Öjvind Davidsson; Anne Ertan; Kristin Goldberg; Sam D. Groombridge; Julian A. Hudson; David Laber; Andrew G. Leach; Philip A. MacFaul; Darren Mckerrecher; Adrian Pickup; Paul Schofield; Per H. Svensson; Pernilla Sörme; Joanne Teague

G protein coupled receptor 119 (GPR119) is viewed as an attractive target for the treatment of type 2 diabetes and other elements of the metabolic syndrome. During a program toward discovering agonists of GPR119, we herein describe optimization of an initial lead compound, 2, into a development candidate, 42. A key challenge in this program of work was the insolubility of the lead compound. Small-molecule crystallography was utilized to understand the intermolecular interactions in the solid state and resulted in a switch from an aryl sulphone to a 3-cyanopyridyl motif. The compound was shown to be effective in wild-type but not knockout animals, confirming that the biological effects were due to GPR119 agonism.


Journal of Organic Chemistry | 2011

Thionations Using a P4S10−Pyridine Complex in Solvents Such as Acetonitrile and Dimethyl Sulfone

Jan Bergman; Birgitta Pettersson; Vedran Hasimbegovic; Per H. Svensson

Tetraphosphorus decasulfide (P(4)S(10)) in pyridine has been used as a thionating agent for a long period of time. The moisture-sensitive reagent has now been isolated in crystalline form, and the detailed structure has been determined by X-ray crystallography. The thionating power of this storable reagent has been studied and transferred to solvents such as acetonitrile in which it has proven to be synthetically useful and exceptionally selective. Its properties have been compared with the so-called Lawesson reagent (LR). Particularly interesting are the results from thionations at relatively high temperatures (∼165 °C) in dimethyl sulfone as solvent. Under these conditions, for instance, acridone and 3-acetylindole could quickly be transformed to the corresponding thionated derivatives. Glycylglycine similarly gave piperazinedithione. At these temperatures, LR is inefficient due to rapid decomposition. The thionated products are generally cleaner and more easy to obtain because in the crystalline reagent, impurities which invariably are present in the conventional reagents, P(4)S(10) in pyridine or LR, have been removed.


Journal of Materials Chemistry | 2016

Layered 2D alkyldiammonium lead iodide perovskites: synthesis, characterization, and use in solar cells

Majid Safdari; Per H. Svensson; Minh Tam Hoang; Ilwhan Oh; Lars Kloo; James M. Gardner

The synthetic route and properties of three 2D hybrid organic/inorganic lead iodide perovskite materials are reported. The 2D perovskites were synthesized from the reaction between PbI2 and the di-cations of 1,4-diaminobutane, 1,6-diaminohexane, and 1,8-diaminooctane. The resulting products were [NH3(CH2)4NH3]PbI4 (BdAPbI4), [NH3(CH2)6NH3]PbI4 (HdAPbI4), and [NH3(CH2)8NH3]PbI4 (OdAPbI4). Structural characterization shows that two dimensional perovskite structures were formed with inorganic structural planes separated by organic layers. Absorption spectra show band gaps of 2.37 eV (BdAPbI4), 2.44 eV (HdAPbI4), and 2.55 eV (OdAPbI4). The 2D perovskite materials were investigated as light absorbing materials in solid state solar cells. The best performing material under moist, ambient conditions was BdAPbI4 (1.08% efficiency), which was comparable to methylammonium Pb(II) iodide (MAPbI3) solar cells (2.1% efficiency) manufactured and studied under analogous conditions. When compared to MAPbI3, the 2D materials have larger band gaps and lower photoconductivity, while BdAPbI4 based solar cells shows a comparable absorbed photon-to-current efficiency as compared to MAPbI3 based ones.


Journal of Medicinal Chemistry | 2013

Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1)

Sofia Karlström; Gunnar Nordvall; Daniel Sohn; Andreas Hettman; Kristofer Åhlin; Annika Kers; Martina Claesson; Can Slivo; Yvonne Lo-Alfredsson; Carl Petersson; Galina Bessidskaia; Per H. Svensson; Tobias Rein; Eva Jerning; Åsa Malmberg; Charlotte Ahlgen; Colin Ray; Lauri Vares; Vladimir Ivanov; Rolf Johansson

We have developed two parallel series, A and B, of CX3CR1 antagonists for the treatment of multiple sclerosis. By modifying the substituents on the 7-amino-5-thio-thiazolo[4,5-d]pyrimidine core structure, we were able to achieve compounds with high selectivity for CX3CR1 over the closely related CXCR2 receptor. The structure-activity relationships showed that a leucinol moiety attached to the core-structure in the 7-position together with α-methyl branched benzyl derivatives in the 5-position displayed promising affinity, and selectivity as well as physicochemical properties, as exemplified by compounds 18a and 24h. We show the preparation of the first potent and selective orally available CX3CR1 antagonists.


ACS Medicinal Chemistry Letters | 2012

Synthesis and Functionalization of Cyclic Sulfonimidamides: A Novel Chiral Heterocyclic Carboxylic Acid Bioisostere

Nils Pemberton; Henrik Graden; Emma Evertsson; Emma Bratt; Matti Lepistö; Petra Johannesson; Per H. Svensson

An efficient synthesis of aryl substituted cyclic sulfonimidamides designed as chiral nonplanar heterocyclic carboxylic acid bioisosteres is described. The cyclic sulfonimidamide ring system could be prepared in two steps from a trifluoroacetyl protected sulfinamide and methyl ester protected amino acids. By varying the amino acid, a range of different C-3 substituted sulfonimidamides could be prepared. The compounds could be further derivatized in the aryl ring using standard cross-coupling reactions to yield highly substituted cyclic sulfonimidamides in excellent yields. The physicochemical properties of the final compounds were examined and compared to those of the corresponding carboxylic acid and tetrazole derivatives. The unique nonplanar shape in combination with the relatively strong acidity (pK a 5-6) and the ease of modifying the chemical structure to fine-tune the physicochemical properties suggest that this heterocycle can be a valuable addition to the range of available carboxylic acid isosteres.


Inorganic Chemistry | 2008

Dimensional Caging of Polyiodides

Per H. Svensson; Mikhail Gorlov; Lars Kloo

Two series of iodide and polyiodide chain structures have been synthesized through the employment of secondary interactions between polycation, long-chain, hydrocarbon cations. These compounds represent examples of crystal engineering, employing a simple strategy of synthesis. The two series are related, and the capacity to incorporate polyiodide ions dependent on the length of the hydrocarbon chains is indicated.


Journal of Materials Chemistry | 2016

Bis(1,1-bis(2-pyridyl)ethane)copper(I/II) as an efficient redox couple for liquid dye-sensitized solar cells

Jiayan Cong; Dominik Kinschel; Quentin Daniel; Majid Safdari; Erik O. Gabrielsson; Hong Chen; Per H. Svensson; Licheng Sun; Lars Kloo

A new redox couple, [Cu(bpye)2]+/2+, has been synthesized, and applied in dye-sensitized solar cells (DSSCs). Overall efficiencies of 9.0% at 1 sun and 9.9% at 0.5 sun were obtained, which are considerably higher than those obtained for cells containing the reference redox couple, [Co(bpy)3]2+/3+. These results represent a record for copper-based complex redox systems in liquid DSSCs. Fast dye regeneration, sluggish recombination loss processes, faster electron self-exchange reactions and suitable redox potentials are the main reasons for the observed increase in efficiency. In particular, the main disadvantage of cobalt complex-based redox couples, charge-transport problems, appears to be resolved by a change to copper complex redox couples. The results make copper complex-based redox couples very promising for further development of highly efficient DSSCs.


ChemMedChem | 2011

Solid-State Perturbation for Solubility Improvement: A Proof of Concept

Lars-Erik Briggner; Ramon Hendrickx; Lars Kloo; Jan Rosdahl; Per H. Svensson

Simple and rational: The intrinsic solubility of a compound can be systematically improved by perturbing key interactions in its crystal structure. By carefully choosing the perturbation, the end r ...


Journal of Medicinal Chemistry | 2014

Circumventing Seizure Activity in a Series of G Protein Coupled Receptor 119 (GPR119) Agonists

James S. Scott; Suzanne S. Bowker; Katy J. Brocklehurst; Hayley S. Brown; David S. Clarke; Alison Easter; Anne Ertan; Kristin Goldberg; Julian A. Hudson; Stefan Kavanagh; David Laber; Andrew G. Leach; Philip A. MacFaul; Darren Mckerrecher; Paul Schofield; Per H. Svensson; Joanne Teague

Agonism of GPR119 is viewed as a potential therapeutic approach for the treatment of type II diabetes and other elements of metabolic syndrome. During progression of a previously disclosed candidate 1 through mice toxicity studies, we observed tonic-clonic convulsions in several mice at high doses. An in vitro hippocampal brain slice assay was used to assess the seizure liability of subsequent compounds, leading to the identification of an aryl sulfone as a replacement for the 3-cyano pyridyl group. Subsequent optimization to improve the overall profile, specifically with regard to hERG activity, led to alkyl sulfone 16. This compound did not cause tonic-clonic convulsions in mice, had a good pharmacokinetic profile, and displayed in vivo efficacy in murine models. Importantly, it was shown to be effective in wild-type (WT) but not GPR119 knockout (KO) animals, consistent with the pharmacology observed being due to agonism of GPR119.

Collaboration


Dive into the Per H. Svensson's collaboration.

Top Co-Authors

Avatar

Lars Kloo

Royal Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew G. Leach

Liverpool John Moores University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge